Parisi Gray Wealth Management Biogen Inc. Transaction History

Parisi Gray Wealth Management

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $165,285 - $208,251	-853 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$282.99 - $369.05 $16,979 - $22,143	-60 Reduced 6.57%	853 $242,000
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $3,495 - $4,433	-13 Reduced 1.4%	913 $289,000
Q4 2019 Jan 24, 2020	SELL	$220.06 - $304.07 $1,320 - $1,824	-6 Reduced 0.64%	926 $275,000
Q3 2019 Oct 09, 2019	SELL	$217.44 - $243.88 $4,348 - $4,877	-20 Reduced 2.1%	932 $217,000
Q2 2019 Jul 19, 2019	SELL	$219.29 - $241.72 $3,947 - $4,350	-18 Reduced 1.86%	952 $223,000
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $108,355 - $169,480	-500 Reduced 34.01%	970 $229,000
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $86,269 - $102,814	335 Added 29.52%	1,470 $525,000
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $3,641 - $5,150	-14 Reduced 1.22%	1,135 $302,000
Q4 2017 Feb 13, 2018	BUY	$307.64 - $344.58 $353,478 - $395,922	1,149	1,149 $384,000

1,035

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Parisi Gray Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Parisi Gray Wealth Management with notifications on news.